| Carolinas Medical Center/behav Health | |
| 1000 Blythe Blvd, Charlotte, North Carolina 28203 | |
| (704) 355-2000 | |
| Name | Carolinas Medical Center/behav Health |
|---|---|
| Type | Acute Care Hospital |
| Location | 1000 Blythe Blvd, Charlotte, North Carolina |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 340113 |
| NPI Number | 1023362571 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-355-3176 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1255501235 |
| Organization Name | CAROLINAS HEALTHCARE SYSTEM |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 704-355-1210 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1295789907 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-355-2000 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1316289416 |
| Organization Name | SHANNON HYDE, NP |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-355-2000 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1346648235 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-355-2000 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1366870503 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 704-355-2000 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1699829887 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Doing Business As | LEVINE CHILDREN'S HOSPITAL PEDIATRICS |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | Rehabilitation Hospital - Children |
| Phone Number | 704-355-2000 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1790727550 |
| Organization Name | CAROLINAS REHABILITATION |
| Address | 1100 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 704-355-4300 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1821467911 |
| Organization Name | CAROLINAS MEDICAL CENTER |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-446-5185 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| NPI Number | 1982930533 |
| Organization Name | CAROLINAS MEDICAL CENTER/CAROLINAS HEALTHCARE SYSTEM |
| Address | 1000 Blythe Blvd, Charlotte, NC 28203 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 704-355-2374 |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Scientists at the University of Bonn identify previously unknown disease mechanism. A congenital disorder of the fat metabolism can apparently cause chronic hyperreaction of the immune system.
Sanford Health Children's Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified.
Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 7 days ago
Novant Health Presbyterian Medical Center Acute Care Hospital Location: 200 Hawthorne Lane Box 33549, Charlotte, North Carolina 28233 Phone: (704) 384-4000 | |
Carolinas Medical Center-pineville Acute Care Hospital Location: 10628 Park Rd, Charlotte, North Carolina 28210 Phone: (704) 379-5000 | |
Carolinas Medical Center/behav Health Acute Care Hospital Location: 1000 Blythe Blvd, Charlotte, North Carolina 28203 Phone: (704) 355-2000 | |
Atrium Health University City Acute Care Hospital Location: 8800 North Tyron Street, Charlotte, North Carolina 28262 Phone: (704) 548-6000 | |
Novant Health Mint Hill Medical Center Acute Care Hospital Location: 8201 Healthcare Loop, Charlotte, North Carolina 28215 Phone: (704) 384-4089 |